Project Grant K08AR085766
Award Date
7/1/25
Completion Date
5/31/30
Dollars Obligated
$170K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
This federal Project Grant award, with an ID of DP2AR085223, was issued by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,656,000 grant, awarded on September 4, 2024, supports research at the Scripps Research Institute in La Jolla, CA to investigate the regulation of inflammation by nociception (sensory perception of pain or other unpleasant stimuli). The research aims to uncover how endogenous opioid...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $172,700 Project Grant (CFDA 93.846 Arthritis, Musculoskeletal and Skin Diseases Research) to the University of California, Irvine to develop and characterize cell-penetrating botulinum protease variants that can inhibit neurotransmitter release and immune cell signaling in skin. The goal is to create a new topical therapeutic strategy to regulate inflammation in skin diseases like psoriasis and atopic...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $196,460 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to the University of Pittsburgh. The purpose of this 30-month grant, with a start date of January 30, 2025, is to develop and utilize a novel microphysiological system to study neuro-immune interactions that contribute to osteoarthritis (OA) pain. The research aims to: 1) understand how inflammatory molecules from...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research, provides $2,076,350.00 to Virginia Commonwealth University for a 5-year research project to investigate the role of sphingolipid biosynthesis in the epidermal barrier, both in healthy skin and skin diseases like atopic dermatitis. The project will utilize organoid culture systems and animal models to...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research federal grant program (CFDA 93.846), is focused on investigating the role of Staphylococcus aureus-induced itch and neuro-immune signaling in driving skin inflammation and atopic dermatitis. The $100,138 award, spanning from August 1, 2024 to July 31, 2026, will support research at Harvard Medical School to: 1) define the...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $126,174.00 to support research aimed at investigating the local immune response and granulopoiesis (production of neutrophils) in human skin during bacterial infections. The primary objectives of this 2.5-year project are to: 1) Demonstrate the role of the SDF-1/CXCR4 signaling axis in attracting and...
The Regents of the University of California, San Francisco (UCSF) was awarded a $343,904 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant, titled "Investigating Single-T Cell Atopic Gene Networks in Asian and Hispanic Genetic Backgrounds", aims to identify genetic abnormalities and functionally characterize transcriptional changes in...
This federal Project Grant award, valued at $198,782 and awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will enable Duke University to develop 3D reconstructed human epidermis (RHE) culture models with CRISPR/Cas9 gene knockouts. These models will be used to investigate interactions between the skin microbiome and skin cell populations, including the effects of...
This $176,148 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will fund a 5-year research and career development plan for Dr. Maxime Kinet. The objective is to elucidate the mechanisms by which PI16-expressing fibroblasts, a conserved cell subset across tissues and species, respond to and regulate fibrosis in mouse and human fibrosing skin diseases. The...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will provide $401,433 from September 2023 to August 2025 to support research at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The research aims to investigate the role of protein O-GlcNAcylation in regulating keratinocyte function and its impact on skin...